|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| REVENUE | |||||
| COST OF REVENUE | |||||
| GROSS LOSS | |||||
| OPERATING EXPENSES: | |||||
| Research and development, net | |||||
| Sales and Marketing | |||||
| General and administrative | |||||
| Goodwill impairment | |||||
| Change in contingent earnout liability | |||||
| Impairment of long-lived assets | |||||
| Other expenses (income) | |||||
| TOTAL OPERATING EXPENSES | |||||
| OPERATING LOSS | |||||
| REALIZED INCOME (LOSS) FROM SALE OF MARKETABLE SECURITIES | |||||
| FINANCIAL INCOME, net | |||||
| OPERATING LOSS BEFORE INCOME TAXES | |||||
| INCOME TAX BENEFIT | |||||
| NET LOSS | |||||
| Reclassification of net losses realized in income statement | |||||
| Reclassification of net losses (income) realized in income statement | |||||
| Unrealized gain from marketable securities | |||||
| Total other comprehensive income: | |||||
| TOTAL COMPREHENSIVE LOSS | |||||
| BASIC LOSS PER SHARE (in Dollars per share) | |||||
| DILUTED LOSS PER SHARE (in Dollars per share) | |||||
| WEIGHTED AVERAGE NUMBER OF BASIC ORDINARY SHARES OUTSTANDING (IN THOUSANDS) (in Shares) | |||||
| WEIGHTED AVERAGE NUMBER OF DILUTED ORDINARY SHARES OUTSTANDING (IN THOUSANDS) (in Shares) | |||||
Loading...
